(4R,5R)-5-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-(1-PYRROLIDINYLMETHYL)-2-OXAZOLIDINONE
UNII 857F77F5NK
Substance Identification & Data
This profile provides standardized clinical and technical data for (4r,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(1-pyrrolidinylmethyl)-2-oxazolidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 857F77F5NK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1821032-96-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H20N2O4 MGHWZOBJJLPNDJ-IUODEOHRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4r,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(1-pyrrolidinylmethyl)-2-oxazolidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.